Monoclonal Antibody Development Articles & Analysis
8 articles found
Small-molecule inhibitors and monoclonal antibodies have been developed to reduce pathological LPA production in cancer, fibrosis, and inflammatory diseases. ...
Among the various production systems available, Chinese Hamster Ovary (CHO) cells have emerged as a gold standard for monoclonal antibody production, and specialized services have been developed to streamline this process. ...
Alfa Cytology has officially released its antibody-drug conjugates(ADCs) development services which demonstrates the dedication to fighting cancer through advanced treatment methods. ...
The COVID-19 pandemic has illuminated the critical need for innovative strategies in antiviral research, and scientists worldwide are embarking on groundbreaking projects to develop more effective therapies, vaccines, and preventive measures against a myriad of viral pathogens The Rise of Next-Generation Antivirals One of the most promising frontiers in antiviral research is ...
Monoclonal antibodies are highly specific biological molecules that are crucial in many areas like disease diagnosis, treatment, and biomarker discovery. They can trigger an immune response in the human body by recognizing and binding to specific antigens, thereby combating pathogens. However, to develop monoclonal ...
The process of developing monoclonal antibodies begins with the identification of a suitable target antigen. ...
But it was not until 1975, when hybridoma technology began to be used to produce monoclonal antibodies, that the era of ADC drug development truly began. ...
Glycans can serve as a source for the development of novel clinical biomarkers that provide a range of specific targets for therapeutic intervention. ...